Sara Hurvitz

Medical Director, JCCC Clinical Research Unit at Jonsson Comprehensive Cancer Center

Sara Hurvitz

Sara Hurvitz

Medical Director, JCCC Clinical Research Unit at Jonsson Comprehensive Cancer Center

Overview
RelSci Relationships

533

Number of Boards

1

Relationships
RelSci Relationships are individuals Sara Hurvitz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director, Clinical & Translational Research at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Vice Chair-Microbiology, Immunology & Molecular Genetics at University of California, Los Angeles - David Geffen School of Medicine

Relationship likelihood: Strong

Co-Founder at Tango Therapeutics, Inc.

Relationship likelihood: Strong

Chair, Department of Radiation Oncology at University of California, Los Angeles - David Geffen School of Medicine

Relationship likelihood: Strong

Director, Shared Resources at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Co-Director, CNS Stereotactic Radiosurgery (SRS) Program at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Director, Informatics at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Director, Cancer Prevention & Control Research at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Director, Department of Medicine Biostatistics Core at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Director, Strategic Planning & Partnerships at Jonsson Comprehensive Cancer Center

Relationship likelihood: Strong

Paths to Sara Hurvitz
Potential Connections via
Relationship Science
You
Sara Hurvitz
Medical Director, JCCC Clinical Research Unit at Jonsson Comprehensive Cancer Center
Career History
Medical Director, JCCC Clinical Research Unit
Current
Assistant Clinical Professor, Department of Medicine, Hematology & Oncology
Current

The University of California, Los Angeles School of Medicine known as the David Geffen School of Medicine at UCLA, is an accredited medical school located in Los Angeles, California, USA.

Boards & Committees
Member, Scientific Advisory Board
Current

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded in January 2012 by Brian Sullivan and Lance Laing and is headquartered in Minneapolis, MN.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sara Hurvitz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sara Hurvitz's profile does not indicate a business or promotional relationship of any kind between RelSci and Sara Hurvitz.